MINT-CAPECITABINE
Identification of Mint-Capecitabine
No description |
Google image searchProduct monograph
Active ingredient
capecitabine, 500 MG
DIN: 02508028
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: MINT PHARMACEUTICALS INC
Date: 05-OCT-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC06 — CAPECITABINE (ATC/DDD)
Reference brand drug: Xeloda
Pharmaceutical standard: USP
External Links for Mint-Capecitabine
Search on Google
- Mint-Capecitabine side effects
- Mint-Capecitabine dosage
- capecitabine side effects
- capecitabine dosage
Mint Pharmaceuticals Inc
Go to Mint website to see drug product details. Sometimes you can find mint-capecitabine photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.